Judah Friedman, MD
- Clinical Assistant Professor
- Benign Hematology
- Breast Cancer
- Genitourinary Oncology
- Liver Cancers
- Malignant Hematology
- Multiple Myeloma
Patient Satisfaction Reviews
4.9 out of 5
Patient Comments (10)
Reviewed On 12/29/2018
Kind, compassionate, knowledgeable physician who has complete respect for his patient. Excellent doctor!
Reviewed On 12/23/2018
in my opinion, Dr Friedman is an excellent doctor who explains everything he does and gave me the results of my*****in a manor of which is in layman's terms.No misunderstandings.
Reviewed On 12/22/2018
Very good experience with Dr. Friedman. ***** ***** *****
Reviewed On 12/17/2018
Very well satisfied with my session with my provider , Dr. was more informative than I expected and was very attentive and kind.
Reviewed On 12/15/2018
Staff is great. Friendly and very professional. Dr. Friedman is outstanding,
Reviewed On 12/14/2018
I have the best oncologist physician that UH has.
Reviewed On 12/9/2018
overall everyone there and the nursing staff at the hospital were right on key, they knew what to do and when to do it, so keep up the great work, *****
Reviewed On 11/25/2018
Dr Friedman is an excellent Dr who has been a great caregiver for me. I recommend him to anyone who needs a good*****Dr.
Reviewed On 11/23/2018
confident that Dr Friedman is doing a great job helping me fight the cancer
Reviewed On 11/19/2018
Dr. Friedman is one of the finest physician's I have ever experienced. His care and manner is excellent!
- Hematology - American Board of Internal Medicine
- Medical Oncology - American Board of Internal Medicine
- Internal Medicine - American Board of Internal Medicine
Fellowship | Hematology/Oncology
Hematology/Oncology - University Of Michigan Hospitals And Health Centers (2004 - 2007)
Residency | Internal Medicine
Internal Medicine - Barnes-Jewish Hospital (2002 - 2004)
Internship | Internal Medicine
Internal Medicine - Barnes-Jewish Hospital (2001 - 2002)
Case Western Reserve University School Of Medicine (2001)
Princeton University (1997)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Judah Friedman disclosed the following Outside Relationships with Industry:
- - Abbott/Abbive - Ownership